News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Blue Rush: One Company Leads the Race to Own Marine Genetic Sequences
Ruth Williams | Jun 6, 2018
Almost half of all patents relating to the genes of marine organisms belong to one large international corporation, BASF, a new study reveals.
Do Patents Promote or Stall Innovation?
Catherine Offord | Jun 1, 2016
A petition recently filed with the Supreme Court triggers renewed debate about the role of patents in the diagnostics sector.
Myriad, Post Mortem
Staff | Jun 1, 2016
David Schwartz of the Illinois Institute of Technology-Chicago, Kent College of Law, discusses the impact of the US Supreme Court unanimously striking down Myriad Genetics' patent of human BRCA genes and tests to detect mutations in them.
Picks: January 29, 2014
Tracy Vence | Jan 29, 2015
Celebrating lab techs; Myriad settles suits; publish in top-tier journals or perish
Australian Court Upholds Patents on Human Genes
Molly Sharlach | Sep 8, 2014
The Federal Court of Australia rejected an appeal of a ruling that allows companies to patent isolated human genes.
Guidelines for Gene Patent Ruling
Jef Akst | Mar 7, 2014
The USPTO offers guidance to its patent examiners on how to interpret the Supreme Court’s rulings in the recent Myriad and Prometheus cases.
The Scientist on The Pulse #2
Kerry Grens | Jan 8, 2014
Kerry Grens looks back at the biggest science stories in 2013
Genetics Firm Gets Baby-Predicting Patent
Bob Grant | Oct 4, 2013
23andMe denies that its new patent will be used to help couples create designer babies based on personal genetic testing.
Speaking of Science
Staff | Aug 1, 2013
August 2013's selection of notable quotes
Another Lawsuit over Genetic Tests
Kate Yandell | Jul 11, 2013
Myriad Genetics, the company originally behind tests for the cancer-associated BRCA mutations, is suing two competitors for patent infringement.